Skip to content
Sign in
Artwork for The Integration Session
The Integration Session · August 6 · 28 min

Research Recap 2: Recent Papers in Psychedelic Science Explained

Want to stay updated on the latest advancements in psychedelic science without reading lengthy scientific papers? Welcome back to Research Recap, where Elena breaks down three recent studies in psychedelic science, in a digestible format. This episode covers a phase IIa trial of short-acting intravenous DMT for depression, a multimodal neuroimaging study of a first psilocybin experience, and an international mega-analysis that informs our understanding of how psychedelics alter brain function. Elena provides a clear breakdown of what the researchers did, why it matters, and the critical details often missed by mainstream media.

0:00-28:55
Play in

transcript

No transcript — this publisher did not publish one.

show notes

Want to stay updated on the latest advancements in psychedelic science without reading lengthy scientific papers? Welcome back to Research Recap, where Elena breaks down three recent studies in psychedelic science, in a digestible format. This episode covers a phase IIa trial of short-acting intravenous DMT for depression, a multimodal neuroimaging study of a first psilocybin experience, and an international mega-analysis that informs our understanding of how psychedelics alter brain function. Elena provides a clear breakdown of what the researchers did, why it matters, and the critical details often missed by mainstream media.

more episodes

All episodes